Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14075 | 729 | 31.0 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
79 | 26608 | DIABETES CARE//DIABETES EDUCATOR//DIABETES TECHNOLOGY & THERAPEUTICS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CORE DIABETES MODEL | Author keyword | 6 | 100% | 1% | 4 |
2 | DIABETES RELATED COMPLICATIONS | Author keyword | 3 | 28% | 1% | 9 |
3 | ROYAL NEW ZEALAND GEN PRACTITIONERS UNIT | Address | 2 | 67% | 0% | 2 |
4 | COST OF DIABETES | Author keyword | 1 | 100% | 0% | 2 |
5 | COST OF DIABETES CARE | Author keyword | 1 | 100% | 0% | 2 |
6 | DESIGNED ABSORPTION | Author keyword | 1 | 100% | 0% | 2 |
7 | THE NATIONAL HOSPITAL AMBULATORY MEDICAL CARE SURVEY NHAMCS | Author keyword | 1 | 100% | 0% | 2 |
8 | UKPDS | Address | 1 | 100% | 0% | 2 |
9 | GLOBAL HLTH OUTCOMES HLTH TECHNOL ASSESSMEN | Address | 1 | 40% | 0% | 2 |
10 | MED POLICY PRACTICE | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTENSIVE BLOOD GLUCOSE | 11 | 52% | 2% | 15 |
2 | HEALTH RELATED UTILITY | 3 | 39% | 1% | 7 |
3 | UKPDS OUTCOMES MODEL | 3 | 100% | 0% | 3 |
4 | EPIDEMIOLOGIC CHANGES | 3 | 60% | 0% | 3 |
5 | WORKFORCE PARTICIPATION | 2 | 67% | 0% | 2 |
6 | EXCESS COSTS | 2 | 29% | 1% | 5 |
7 | LIFETIME HEALTH OUTCOMES | 2 | 43% | 0% | 3 |
8 | DIRECT MEDICAL COSTS | 2 | 14% | 2% | 11 |
9 | ARCHIMEDES | 2 | 16% | 1% | 9 |
10 | UKPDS | 2 | 11% | 2% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cost-of-illness studies of diabetes mellitus: A systematic review | 2014 | 3 | 40 | 50% |
Burden of Diabetes on the Ability to Work A systematic review | 2013 | 8 | 34 | 44% |
Cost-of-illness studies in diabetes mellitus | 2004 | 85 | 30 | 53% |
Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus | 2014 | 4 | 23 | 30% |
The impact of diabetes mellitus on healthcare costs in Italy | 2011 | 12 | 40 | 43% |
Economic models in type 2 diabetes | 2010 | 9 | 51 | 65% |
Economic impact of antidiabetic medications and glycemic control on managed care organizations: A review of the literature | 2006 | 29 | 37 | 30% |
Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review | 2014 | 1 | 25 | 40% |
The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies | 2013 | 1 | 14 | 57% |
The Economic Costs of Type 2 Diabetes: A Global Systematic Review | 2015 | 0 | 102 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ROYAL NEW ZEALAND GEN PRACTITIONERS UNIT | 2 | 67% | 0.3% | 2 |
2 | UKPDS | 1 | 100% | 0.3% | 2 |
3 | GLOBAL HLTH OUTCOMES HLTH TECHNOL ASSESSMEN | 1 | 40% | 0.3% | 2 |
4 | MED POLICY PRACTICE | 1 | 40% | 0.3% | 2 |
5 | CENEXA | 1 | 21% | 0.5% | 4 |
6 | AUSTRALIAN DIABET STRATEGIES | 1 | 50% | 0.1% | 1 |
7 | CATEDRA INVEST SALUD | 1 | 50% | 0.1% | 1 |
8 | CLIN ECON COST OUTCOMES | 1 | 50% | 0.1% | 1 |
9 | ENDOCRINE FIROOZGAR | 1 | 50% | 0.1% | 1 |
10 | EXPT PL ENDOCRINOL CENEXA | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000215940 | UNIDAD INVEST DIABET RIESGO CARDIOVASC//BORDER HEALTH//ESTUDIOS DIABET |
2 | 0.0000182527 | DIABETES PREVALENCE//HOSPITAL ADMISSION RATES//ALLIANCE CLIN TRIALS |
3 | 0.0000169659 | CHRONIC CARE MODEL//PACIC//DIABETES CARE |
4 | 0.0000156023 | INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30 |
5 | 0.0000149368 | PMV FOR GRP//ZENTRUM SOZIALPOLIT ZES//SHI ROUTINE DATA |
6 | 0.0000139547 | REGIME AMPI//SERV MED ASSURANCE MALAD//ECHELON |
7 | 0.0000134560 | IMPAIRED FASTING GLUCOSE//DIABETES PREVENTION//IMPAIRED GLUCOSE TOLERANCE |
8 | 0.0000116026 | GRP RIESGO CARDIOVASC NUTR//SALUD MARINA//SERV INVEST INNOVAC FORMAC SANITARIA |
9 | 0.0000105436 | S AUCKLAND DIABET PROJECT//MAORI INDIGENOUS HLTH//GEOGRAPHICAL DISADVANTAGE |
10 | 0.0000095235 | IDOP//DIABET OLDER PEOPLE IDOP//ADMINISTRATIVE HEALTH CARE UTILIZATION DATA |